|
|
|
Solid Biosciences Inc 
|
6.8 0.38 (0.06%) |
01-25 16:00 |
Open: |
6.42 |
Pre close: |
6.42 |
Target:
|
8.77
|
High: |
6.8999 |
Low: |
6.22 |
Resistance:
|
7.51
8.56
|
Volume: |
704,320 |
Market Cap: |
576M |
Support:
|
5.81
4.83
|
|
|
|
Technical Analysis |
Moving Averages |
MA(5):
|
6.33
 |
MACD |
MACD(12,26):
|
0.21  |
MA(20): |
6.86  |
Signal(12,26,9): |
0.38  |
MA(100): |
4.19  |
Stochastic Oscillator |
%K(14,3):
|
26.11  |
MA(250): |
3.38  |
%D(3): |
17.62  |
Average Volume(K) |
3-Month: |
187177
|
52-Week |
High:
|
8.56 |
10-Days: |
86086 |
Low: |
1.93 |
RSI |
RSI(14):
|
55.09  |
Change(%): |
98.3 |
Financials, Statistics and Valuation |
EPS |
-2.050 |
Return on Equity (ttm) |
-151.1 |
Shares Out. (M) |
84.77 |
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-71.1 |
Shares Float (M) |
14.84 |
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
32.32 |
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
67.38 |
Forward EPS |
-2.910 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
2450 |
Book Value (p.s.) |
0.480 |
EBITDA (p.s.) |
-1.103 |
P/E |
-3.32 |
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
14.17 |
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-79.15 |
P/S |
0.00 |
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-42.74 |
P/CF |
-7.28 |
|
|
|
|
|